Henrik Green
Henrik Green
Dirección de correo verificada de liu.se
TítuloCitado porAño
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
MMH Christensen, C Brasch-Andersen, H Green, F Nielsen, P Damkier, ...
Pharmacogenetics and genomics 21 (12), 837-850, 2011
2052011
mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy
H Green, P Söderkvist, P Rosenberg, G Horvath, C Peterson
Clinical Cancer Research 12 (3), 854-859, 2006
1802006
Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer
H Green, P Söderkvist, P Rosenberg, RA Mirghani, P Rymark, ...
Basic & clinical pharmacology & toxicology 104 (2), 130-137, 2009
1362009
Impact of CYP2C8* 3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer
TK Bergmann, C Brasch-Andersen, H Green, M Mirza, RS Pedersen, ...
PHARMACOGENOMICS JOURNAL 11 (2), 113-120, 0
97*
Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer
TK Bergmann, H Gréen, C Brasch-Andersen, MR Mirza, J Herrstedt, ...
European journal of clinical pharmacology 67 (7), 693-700, 2011
792011
Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia
J Gregers, H Green, IJ Christensen, K Dalhoff, H Schroeder, N Carlsen, ...
The pharmacogenomics journal 15 (4), 372, 2015
632015
ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel
H Green, P Söderkvist, P Rosenberg, G Horvath, C Peterson
Journal of pharmaceutical sciences 97 (6), 2045-2048, 2008
612008
Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy
LJ Leandro-García, S Leskelä, C Jara, H Gréen, E Åvall-Lundqvist, ...
Clinical Cancer Research 18 (16), 4441-4448, 2012
552012
Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy
LJ Leandro-García, L Inglada-Pérez, G Pita, E Hjerpe, S Leskelä, C Jara, ...
Journal of medical genetics 50 (9), 599-605, 2013
482013
Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype
H Green, IJ Falk, K Lotfi, E Paul, M Hermansson, R Rosenquist, C Paul, ...
The pharmacogenomics journal 12 (2), 111, 2012
472012
Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice
AJ Lopez-Contreras, J Specks, JH Barlow, C Ambrogio, C Desler, ...
Genes & development 29 (7), 690-695, 2015
412015
Impact of ABCB1 Variants on Neutrophil Depression: A Pharmacogenomic Study of Paclitaxel in 92 Women with Ovarian Cancer
TK Bergmann, C Brasch‐Andersen, H Gréen, MR Mirza, K Skougaard, ...
Basic & clinical pharmacology & toxicology 110 (2), 199-204, 2012
392012
In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-isobutyrylfentanyl
S Watanabe, S Vikingsson, M Roman, H Green, R Kronstrand, ...
The AAPS journal 19 (4), 1102-1122, 2017
382017
CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity
H Gréen, K Skoglund, F Rommel, RA Mirghani, K Lotfi
European journal of clinical pharmacology 66 (4), 383-386, 2010
382010
Measurement of paclitaxel and its metabolites in human plasma using liquid chromatography/ion trap mass spectrometry with a sonic spray ionization interface
H Green, K Vretenbrant, B Norlander, C Peterson
Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2006
352006
Identification of AKB-48 and 5F-AKB-48 metabolites in authentic human urine samples using human liver microsomes and time of flight mass spectrometry
S Vikingsson, M Josefsson, H Green
Journal of analytical toxicology 39 (6), 426-435, 2015
302015
Impact of CYP3A5* 3 and CYP2C8‐HapC on paclitaxel/carboplatin‐induced myelosuppression in patients with ovarian cancer
H Green, MS Khan, I Jakobsen‐Falk, E Åvall‐Lundqvist, C Peterson
Journal of pharmaceutical sciences 100 (10), 4205-4209, 2011
302011
A reassessment of DNA-immunoprecipitation-based genomic profiling
A Lentini, C Lagerwall, S Vikingsson, HK Mjoseng, K Douvlataniotis, ...
Nature methods 15 (7), 499, 2018
282018
Pharmacogenetics, plasma concentrations, clinical signs and EEG during propofol treatment
MS Khan, EL Zetterlund, H Gréen, A Oscarsson, AL Zackrisson, ...
Basic & clinical pharmacology & toxicology 115 (6), 565-570, 2014
282014
ABCB1 2677G> T/A genotype and paclitaxel pharmacogenetics in ovarian cancer
S Marsh, CR King, HL McLeod, J Paul, G Gifford, R Brown
Clinical Cancer Research 12 (13), 4127-4129, 2006
282006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20